SC 13G/A: Corvus Pharmaceuticals, Inc.

AI Summary

SC 13G/A filing by Corvus Pharmaceuticals, Inc..

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.0001 — me of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• d11045799_13g-a.htm (SC 13G/A) — 111KB
• 0000919574-24-002861.txt ( ) — 112KB

From the Filing

SC 13G/A 1 d11045799_13g-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Corvus Pharmaceuticals, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 221015100 (CUSIP Number) May 1, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) __________ * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No 221015100 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Samlyn Capital, LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [_] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 6,267,984* 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 6,267,984* 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,267,984* 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.99%* 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IA, OO * Samlyn Capital, LLC (“Samlyn Capital”) is deemed to beneficially own warrants of the issuer (“Warrants”) that are directly owned by certain of Samlyn Capital’s investment advisory clients (such clients, the “Samlyn Clients”). The Warrants, each of which converts into shares of Common Stock on a 1 to 1 basis, are subject to a blocker provision that prevents each Samlyn Client from exercising the Warrants if it or any of its affiliates, including Samlyn Capital, would be more than a 9.99% beneficial owner of the issuer’s outstanding Common Stock following such exercise (the “Blocker Provision”). Accordingly, the number of shares of Common Stock and the percentage of the issuer’s outstanding Common Stock deemed beneficially owned by Samlyn Capital have been adjusted to account for: (i) the maximum amount of Warrants that the Samlyn Clients can collectively exercise, giving effect to the Blocker Provision; and (ii) the additional shares of Common Stock that would be issued by the issuer to the Samlyn Clients in connection with full exercise of the Warrants by the Samlyn Clients, giving effect to the Blocker Provision. CUSIP No 221015100 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Samlyn, LP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [_] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 6,267,984* 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 6,267,984* 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,267,984* 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.99%* 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN * Samlyn, LP is deemed to beneficially own warrants of the issuer (“Warrants”) that are directly owned by certain of Samlyn Capital, LLC’s (“Samlyn Capital”) investment advisory clients (such clients, the “Samlyn Clients”). The Warrants, each of which converts into shares of Common Stock on a 1 to 1 basis, are subject to a blocker provision that prevents each Samlyn Client from exercising the Warrants if it or any of its affiliates, including Samlyn, LP, would be more than a 9.99% beneficial owner of the issuer’s outstanding Common Stock following such exercise (the “Blocker Provision”). Accordingly, the number of shares of Common Stock and the percentage of the issuer’s outstanding Common Stock deemed beneficially owned by Samlyn, LP have been adjusted to account for: (i) the maximum amount of Warrants that the Samlyn Clients can collectively exercise, giving effect to the Blocker Provision;

View Full Filing

View this SC 13G/A filing on SEC EDGAR